CAS 655234-81-4

FTI-2628

CAS : 655234-81-4

FTI-2628 is a pharmacologic agent that has been shown to have an effect on the cell cycle. It is a small molecule that prevents prenylation of proteins and thereby alters the function of the insulin-like growth factor receptor (IGF-1R). FTI-2628 also inhibits matrix metalloproteinase 13 (MMP-13) expression by blocking transcriptional activation of the gene. This drug has been shown to be effective in animal models for osteoarthritis, as well as inhibiting MMP-13 production in cells from patients with rheumatoid arthritis. FTI-2628 has also been shown to be effective in reducing the size of tumors in mouse models of cancer.

Formule : C₃₁H₃₄N₄O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 542.69 g/mol

Ref: 3D-FF171686

FTI-2628

CAS : 655234-81-4

FTI-2628 is a novel inhibitor of protein farnesyltransferase (FT), inhibiting the growth of P. falciparum in red blood cells and suppressing parasitemia.

Formule : C₃₁H₃₄N₄O₃S

Couleur et forme : Solid

Masse moléculaire : 542.69

Ref: TM-T68923